Laboratory Solution Development Scientist

Position Summary

Are you seeking an opportunity where you can contribute to the advancement of biotechnology and genomics in a dynamic laboratory environment? Do you want to apply your scientific expertise to develop innovative laboratory services and solutions in a rapidly growing biotechnology company? If you are eager to work on cutting-edge technologies alongside a collaborative team, join Psomagen’s laboratory operations team.

Psomagen Inc. is a rapidly growing biotechnology company renowned for providing a variety of genomics-based molecular assay solutions to research and clinical communities. We are seeking a highly motivated Laboratory Solution Development Scientist to support research and development of new laboratory services, optimize workflows, and contribute to expanding our genomics and proteomics capabilities.

The ideal candidate will play a key role in developing and validating new bioscience services, supporting Next Generation Sequencing (NGS) and proteomics workflows, and collaborating with internal and external stakeholders to drive innovation and service expansion.

Job Profile

• Full-time 
• Location: Rockville, MD

Responsibilities

• Conduct research in biotechnology and genomics using bioscience theories and methods to develop innovative analytical tools and solutions 
• Collaborate with internal researchers to identify and resolve technical challenges, recommending biotechnology-based solutions 
• Design and validate new bioscience laboratory services within Next Generation Sequencing (NGS) platforms 
• Prepare validation plans, perform feasibility studies, and compile technical reports for internal review and service implementation 
• Deliver technical training and transfer validated protocols to production teams 
• Develop and optimize laboratory workflows for proteomics services, including Olink-based protein analysis 
• Lead automation development and ensure workflows meet regulatory and operational requirements 
• Conduct proof-of-concept and pilot studies, maintaining detailed documentation and supporting technology transfer to routine operations 
• Communicate with customers, including hospitals and universities, to address inquiries related to genomic sequencing services and results 
• Present research findings through reports, publications, and presentations 
• Provide hands-on technical support for troubleshooting NGS services, identifying root causes of assay failures, and implementing corrective actions 
• Evaluate emerging bioscience technologies and service opportunities in collaboration with external partners 
• Lead technical discussions and pilot testing for new genomics workflows and service offerings 

Preferred Qualifications

• Ph.D. degree in Biology, Veterinary Science, or a related field
• Minimum of 6 months of post-graduate experience in the offered position or as a Research & Development Scientist
• Strong knowledge of biotechnology, genomics, and Next Generation Sequencing (NGS) applications
• Experience with laboratory workflow development, validation, and technology transfer
• Strong analytical, problem-solving, and documentation skills
• Excellent communication and collaboration skills

Benefits

• Medical, Dental, and Vision insurance (100% employer-paid premium) 
• 401K with immediate participation and company match after 1 year 
• Paid time-off with roll over option 
• Long-term employment cashable vacation 
• 2-hour off for an annual check-up 
• Lunch allowance and drinkware reimbursement 
• Visa sponsorship is offered when needed 
• Money Gifts for congratulatory/condolences
• Free gym facilities near the company

Company Overview 

Psomagen, Inc., founded in 2004 in Rockville, MD, is at the forefront of genetic and genomic testing. The company offers cutting-edge genomic services through next-generation and Sanger sequencing with data analysis services for applications in basic research and clinic diagnostics. The service laboratory has been certified under the Clinical Laboratory Improvement Amendments (CLIA) and accredited by the College of American Pathologists (CAP), which demonstrates the highest level of quality and safety in the market.

Listed on the KOSDAQ in July 2020, the company is rapidly expanding its business from B2B to B2C and from Research to Clinical markets. The company has broadened the capabilities in the healthcare space such as at-home kits for analysis of genetic traits and microbiome profiles. With CLIA-certified and CAP-accredited laboratories, the company is looking to further expand service offerings in the clinical laboratory diagnostics market such as a laboratory-developed test (LDT) for COVID-19.